AARON L ANDERSON
Physician Assistants & Advanced Practice Nursing Providers|Physician Assistant DES MOINES, IA NPI 1780769323
Browse related groups: Physician Assistants & Advanced Practice Nursing Providers|Physician Assistant IA NOVARTIS PHARMACEUTICALS CORPORATION All categories
General Payments — all program years on this page
$1,609.91
- Category: General Payments
- Program years: PY2021–2024
- Record count: 89
- As of (CMS publication): 2026-01-23
Latest program year (PY2024): $703.02 across 39 records · disputed records: 0
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How this figure is calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
Latest program year (PY2024) · sorted by reported total.
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $683.02 | 38 |
| Education | $20.00 | 1 |
By paying entity
Latest program year (PY2024) · sorted by reported total.
| Paying entity | Amount | Records |
|---|---|---|
| NOVARTIS PHARMACEUTICALS CORPORATION | $50.94 | 3 |
| Genentech USA, Inc. | $45.10 | 2 |
| Celgene Corporation | $36.01 | 2 |
| Acerta Pharma LLC | $35.96 | 2 |
| PFIZER INC. | $35.51 | 2 |
| AVEO Pharmaceuticals, Inc. | $35.40 | 2 |
| ABBVIE INC. | $33.81 | 2 |
| Merck Sharp & Dohme Corporation | $32.51 | 2 |
| Janssen Biotech, Inc. | $30.77 | 2 |
| Takeda Pharmaceuticals U.S.A., Inc. | $28.92 | 1 |
| Blueprint Medicines Corporation | $26.18 | 1 |
| Karyopharm Therapeutics Inc. | $23.06 | 1 |
| Daiichi Sankyo Inc. | $21.88 | 1 |
| Lilly USA, LLC | $20.41 | 1 |
| Ipsen Biopharmaceuticals, Inc | $19.59 | 1 |
| Incyte Corporation | $17.77 | 1 |
| EISAI INC. | $17.40 | 1 |
| ImmunoGen, Inc. | $17.20 | 1 |
| Bayer HealthCare Pharmaceuticals Inc. | $17.07 | 1 |
| Stemline Therapeutics Inc. | $17.05 | 1 |
| Alexion Pharmaceuticals, Inc. | $16.93 | 1 |
| E.R. Squibb & Sons, L.L.C. | $16.86 | 1 |
| Gilead Sciences, Inc. | $16.83 | 1 |
| GlaxoSmithKline, LLC. | $16.79 | 1 |
| Rigel Pharmaceuticals, Inc. | $15.53 | 1 |
| GENZYME CORPORATION | $15.44 | 1 |
| SERVIER PHARMACEUTICALS LLC | $14.62 | 1 |
| PUMA BIOTECHNOLOGY, INC. | $14.20 | 1 |
| TAIHO ONCOLOGY, INC. | $13.28 | 1 |
By program year
Records — PY2024 (39)
Provenance & corrections
- Dataset: CMS Open Payments — General Payments
- Source: CMS Open Payments dataset (bulk file)
- Publisher of source data: Centers for Medicare & Medicaid Services
- Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.